Juan M Fernandez-Costa (Juan M Fernández-Costa)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Disease models & mechanisms

Pharmaceutics

Biomedicines

Biofabrication

Institute for Bioengineering of Catalonia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Bioengineering of Catalonia Sep 16 2019

Spain

Postdoctoral fellow :: Biosensors for Bioengineering

University of Valencia Oct 04 2016 - Sep 15 2019

Spain

Postdoctoral Researcher :: Translational Genomics

INCLIVA Health Research Institute Apr 01 2016 - Sep 30 2016

Spain

Postdoctoral Researcher :: Translational Genomics

University of Valencia Jul 14 2015 - Dec 31 2015

Spain

Specialist Research Assistant :: Translational Genomics

Valentia Biopharma (Spain) Feb 13 2012 - May 31 2015

Spain

Researcher :: R & D

University of Valencia Jun 01 2006 - Feb 10 2012

Spain

PhD Student :: Translational Genomics

Publications

Sheeza Mughal, Maria Sabater-Arcis, Rubén Artero, Javier Ramon-Azcon, Juan M Fernandez-Costa
Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy. Disease models & mechanisms 17 (4) (2024)
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M Fernandez-Costa, Javier Ramon-Azcon
The Tissue Engineering Revolution: From Bench Research to Clinical Reality. Biomedicines 12 (2) (2024)
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M Fernandez-Costa, Javier Ramon-Azcon
The Tissue Engineering Revolution: From Bench Research to Clinical Reality. Biomedicines 12 (2) (2024)
Sheeza Mughal, Maria Sabater-Arcis, Rubén Artero, Javier Ramon-Azcon, Juan M Fernandez-Costa
Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy. Disease models & mechanisms 17 (4) (2024)
Sheeza Mughal, Maria Sabater-Arcis, Rubén Artero, Javier Ramon-Azcon, Juan M Fernandez-Costa
Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy. Disease models & mechanisms 17 (4) (2024)
Sheeza Mughal, Maria Sabater-Arcis, Rubén Artero, Javier Ramon-Azcon, Juan M Fernandez-Costa
Taurine activates the AKT-mTOR axis to restore muscle mass and contractile strength in human 3D in vitro models of steroid myopathy. Disease models & mechanisms 17 (4) (2024)
Ainoa Tejedera-Villafranca, Marisol Montolio, Javier Ramon-Azcon, Juan M Fernandez-Costa
Mimicking sarcolemmal damage in vitro : a contractile 3D model of skeletal muscle for drug testing in Duchenne muscular dystrophy. Biofabrication (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Eva A van Aalen, Bas J H M Rosier, Tom Jansen, Simone F A Wouters, Robin T Vermathen, Harmen J van der Veer, José Yeste Lozano, Sheeza Mughal, Juan M Fernandez-Costa, Javier Ramon-Azcon, Jaap M J den Toonder, Maarten Merkx
Integrated Bioluminescent Immunoassays for High-Throughput Sampling and Continuous Monitoring of Cytokines. Analytical chemistry (2023)
Juan M Fernandez-Costa, Ainoa Tejedera-Villafranca, Xiomara Fernández-Garibay, Javier Ramon-Azcon
Muscle-on-a-chip devices: a new era for in vitro modelling of muscular dystrophies. Disease models & mechanisms 16 (6) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Sarah Joann Overby, Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M Fernandez-Costa, Jordina Balaguer-Trias, Javier Ramon-Azcon, Manuel Pérez-Alonso, Thorleif Møller, Beatriz Llamusí, Rubén Artero
BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA LR Mice. Pharmaceutics 15 (4) (2023)
Xiomara Fernández-Garibay, Manuel Gómez-Florit, Rui M A Domingues, Manuela Estima Gomes, Juan M Fernandez-Costa, Javier Ramon-Azcon
Xeno-free bioengineered human skeletal muscle tissue using human platelet lysate-based hydrogels. Biofabrication 14 (4) (2022)
Francesco De Chiara, Ainhoa Ferret-Miñana, Juan M Fernandez-Costa, Alice Senni, Rajiv Jalan, Javier Ramon-Azcon
Fatty Hepatocytes Induce Skeletal Muscle Atrophy In Vitro: A New 3D Platform to Study the Protective Effect of Albumin in Non-Alcoholic Fatty Liver. Biomedicines 10 (5) (2022)
Juan M Fernandez-Costa, Xiomara Fernández-Garibay, Ferran Velasco-Mallorquí, Javier Ramon-Azcon
Bioengineered in vitro skeletal muscles as new tools for muscular dystrophies preclinical studies. Journal of tissue engineering 12 (2021)
Xiomara Fernández-Garibay, María A Ortega, Estefanía Cerro-Herreros, Jordi Comelles, Elena Martínez, Rubén Artero, Juan M Fernandez-Costa, Javier Ramon-Azcon
Bioengineeredin vitro3D model of myotonic dystrophy type 1 human skeletal muscle. Biofabrication 13 (3) (2021)
Ferran Velasco-Mallorquí, Juan M Fernandez-Costa, Luisa Neves, Javier Ramon-Azcon
New volumetric CNT-doped gelatin-cellulose scaffolds for skeletal muscle tissue engineering. Nanoscale advances 2 (7) (2020)
Estefania Cerro-Herreros, Maria Sabater-Arcis, Juan M Fernandez-Costa, Nerea Moreno, Manuel Perez-Alonso, Beatriz Llamusi, Rubén Artero
miR-23b and miR-218 silencing increase Muscleblind-like expression and alleviate myotonic dystrophy phenotypes in mammalian models. Nature communications 9 (1) (2018)

Juan M Fernandez-Costa.css-eqlu8i{font-size:small;padding-left:4px;} (Juan M Fernández-Costa)

Publication Activity (10 Years)

Top Topics

Top Venues

Juan M Fernandez-Costa (Juan M Fernández-Costa)